Chandra Verma, Bioinformatics Institute in Singapore

The Role of Flexibility in Protein-Protein Interactions and Therapeutic Design
There is increasing interest in designing inhibitors and modulators of pathways in cells for development of novel targeted therapeutics. The traditional approach of designing small molecule and peptide inhibitors using standard tools of docking have served us well but need to be modified to include of the intrinsic dynamics of these systems. In our hands, molecular dynamics simulations are proving to be a useful tool in incorporation of flexibility in docking methods for advancing drug discovery and will be discussed.